CUSIP 874060205SPONSORED ADSTAKQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
342 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Capital Research Global Investors | 13.49M | $210.26M | +82.6K | Added |
| 2 | Morgan Stanley | 6.37M | $99.36M | −1.32M | Reduced |
| 3 | Arrowstreet Capital, Limited Partnership | 5.68M | $88.60M | +2.85M | Added |
| 4 | Goldman Sachs Group Inc | 4.80M | $74.90M |
| −148.8K |
| Reduced |
| 5 | D. E. Shaw & Co., Inc. | 4.29M | $66.94M | +4.01M | Added |
| 6 | Ubs Group AG | 4.12M | $64.29M | −1.77M | Reduced |
| 7 | Fmr LLC | 4.06M | $63.25M | −130.1K | Reduced |
| 8 | Brandes Investment Partners, LP | 3.88M | $60.52M | −49.9K | Reduced |
| 9 | Blackrock, Inc. | 2.73M | $42.59M | −576.0K | Reduced |
| 10 | Renaissance Technologies LLC | 2.62M | $40.82M | −1.25M | Reduced |
See every fund holding Takeda Pharmaceutical Co Ltd, with full quarter-over-quarter share changes.
Unlock all holders